RCH Solutions Increases Support in the Greater Boston Area with the Hiring of Michael Wlodarczyk

A Boston College alum, Wlodarczyk has been tapped to lead RCH’s business development efforts in the Boston-area following a year marked by record-breaking growth.

RCH Solutions (RCH), a global provider of Bio-IT computing expertise for Life Sciences and Healthcare firms of all sizes, announces the hiring of Michael Wlodarczyk as Director of Sales and Business Development. Based out of RCH’s location in Boston, Mass., Wlodarczyk has been tasked to support and grow the company’s already strong presence across the Northeast.

“We continue to see increased demand for specialized scientific computing expertise in the greater Boston area,” says Michel Riener, President of RCH Solutions. “Both biotech start-ups and large pharmas alike are racing toward discovery and seeking ways to scale their R&D IT service model. Adding more resources to our Boston team positions RCH to better support those we already serve as well as those who would benefit from the unmatched specialization of our model.”

Serving Life Sciences and Healthcare companies exclusively for more than 28 years, RCH Solutions delivers focused technical computing expertise that combines scientific rigor with cross-functional IT experience. This niche service is particularly critical to biotech, pharmaceutical, and healthcare companies connecting the increasingly complex worlds of research development and technology to accelerate the advancement of scientific discovery.

Wlodarczyk joins RCH from Randstad Technologies, where he served as Recruiting Director and was responsible for leading IT staffing solutions for organizations around the globe. Growing up in Medford, New Jersey, he attended Boston College, where he played baseball until being drafted by Tampa Bay in the seventh round of the 2005 MLB draft. Wlodarczyk spent the next six years playing professional baseball, reaching AAA Durham Bulls in 2009, before finishing his career with Boston’s Brockton Rox in 2010. He started with Randstad Technologies, then Sapphire Technologies, in December of that same year.

In his new role at RCH, Wlodarczyk will use his unique understanding for the often complex and nuanced scientific-IT support needs of Life Sciences companies to serve and expand the firm’s relationships throughout the Northeast, with a concentration in the Boston area.

“This Life Sciences space is extremely competitive. To succeed—particularly in the world of R&D—teams have to be fast, agile, and, most importantly, hungry for their next breakthrough,” Riener continues. “Not only does Mike bring a depth of knowledge in areas critical to delivering the right technical computing services to our clients and prospects, his experience in professional athletics gives him a competitive edge that can’t be taught. He’s a natural fit for our team and customers in Boston.”

“Though I was immediately drawn to the opportunity to support RCH’s mission and ultimately help drive innovation in the Life Sciences, the current state of the world has only magnified the importance of those scientific initiatives,” Wlodarczyk says. “As teams navigate these uncharted waters, it’s never been more important for organizations to make sure the resources are in place to continue work at the pace necessary. I’m excited to bring my experience to this side of the business and do what I can to support the needs of the IT and scientific communities in Boston.”


About RCH Solutions 
RCH Solutions (RCH) is a global provider of Bio-IT expertise, helping Life Sciences and Healthcare companies of all sizes clear the path to discovery. For more than 28 years, RCH has provided focused experience and unmatched specialization designing and deploying cross-functional IT strategies, supporting R&D infrastructure, and offering workflow best practices that solve enterprise and scientific computing challenges. Learn more at http://www.rchsolutions.com

“Adding more resources to our Boston team positions RCH to better support those we already serve as well as those who would benefit from the unmatched specialization of our model.”